OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses
Elahe Aleebrahim‐Dehkordi, Bahareh Molavi, Melika Mokhtari, et al.
Transplant Immunology (2021) Vol. 70, pp. 101495-101495
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 367

Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19
Sung Ha Lim, Hyun Jeong Ju, Ju Hee Han, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336120-e2336120
Open Access | Times Cited: 69

The Immunopathogenesis of a Cytokine Storm: The Key Mechanisms Underlying Severe COVID-19
Luka Hiti, Tijana Markovič, Mitja Lainščak, et al.
Cytokine & Growth Factor Reviews (2025)
Open Access | Times Cited: 7

Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability
Kailin Mai, Weiqi Pan, Zhengshi Lin, et al.
Advanced Biotechnology (2025) Vol. 3, Iss. 1
Open Access | Times Cited: 2

A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2
Werner C. Albrich, Tarini Shankar Ghosh, Sinead Ahearn‐Ford, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 57

Immune responses in mildly versus critically ill COVID-19 patients
Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 42

Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
Lily E. Adams, Sarah R. Leist, Kenneth H. Dinnon, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112326-112326
Open Access | Times Cited: 36

COVID-19 and atrial fibrillation: Intercepting lines
Maria Donniacuo, Antonella De Angelis, Concetta Rafaniello, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 24

T4 Phage Displaying Dual Antigen Clusters Against H3N2 Influenza Virus Infection
Shenglong Liu, Mengzhou Lin, Xin Zhou
Vaccines (2025) Vol. 13, Iss. 1, pp. 70-70
Open Access | Times Cited: 1

N-2-Hydroxypropyl Trimethyl Ammonium Chloride Chitosan-Aluminum Nano-Adjuvant Elicit Strong Immune Responses in Porcine Epidemic Diarrhea Inactivated Vaccine
Zheng Jin, Jiali Liu, Sihan Guo, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1321-1334
Open Access | Times Cited: 1

HBV Vaccines: Advances and Development
Faisal Mahmood, Ruixian Xu, Maher Un Nisa Awan, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1862-1862
Open Access | Times Cited: 20

Effect of DMARDs on the immunogenicity of vaccines
Yannick van Sleen, Kornelis S. M. van der Geest, Anke Huckriede, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 560-575
Closed Access | Times Cited: 19

Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug
Bo Zhang, Junjie Tian, Qintao Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 25

Systematic Review of Probiotics and Their Potential for Developing Functional Nondairy Foods
Ricardo S. Alemán, Ajitesh Yadav
Applied Microbiology (2023) Vol. 4, Iss. 1, pp. 47-69
Open Access | Times Cited: 16

COVID‐19‐induced autoimmune thyroiditis: Exploring molecular mechanisms
Bita Mohammadi, Kamal Dua, Mohammadreza Saghafi, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Closed Access | Times Cited: 15

A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection
Zhujun Ao, Maggie Jing Ouyang, Titus Abiola Olukitibi, et al.
Journal of Virology (2022) Vol. 96, Iss. 18
Open Access | Times Cited: 21

Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice
In‐Chan Hwang, Valerie Diane Valeriano, Ji Hoon Song, et al.
Microbial Cell Factories (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12

COVID-19: from immune response to clinical intervention
Zhengyang Guo, Yanqing Tang, Zi-bo Zhang, et al.
Precision Clinical Medicine (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 4

Clara cell 16 kDa protein: an important marker for COVID-19 severity
Tineke Kardol‐Hoefnagel, Bart Luijk, Leon C. Reteig, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study
Carlos Fierro, Nelia Sánchez-Crespo, Daniel Makrinos, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Heterologous Prime-Boost immunization with Adenoviral vector and recombinant subunit vaccines strategies against dengue virus type2
M Mahmoudian Shoushtari, ‪Mostafa Salehi-Vaziri, Maryam Kadkhodazadeh, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114032-114032
Closed Access

Fu Tu Sheng Jin Rehabilitation Formula Mitigate Airway Inflammation, Mucus Secretion and Immune Dysfunction Induced by SARS-CoV-2 Spike Protein
Bo-Han Wang, Keyao Yu, Xiaona Zhang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1053-1065
Open Access

Page 1 - Next Page

Scroll to top